BackLatigo Biotherapeutics Overview

Latigo Biotherapeutics Current Cash

Track Latigo Biotherapeutics's current cash ($400M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$401.24M

Peer trimmed avg / median

Loading

Latigo Biotherapeutics Current Cash History

Loading

Latigo Biotherapeutics vs. peers: Current Cash Comparison

Loading

Latigo Biotherapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Latigo Biotherapeutics (LTGO) FAQ

Latigo Biotherapeutics's current cash stands at $400M as of September 2026. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Latigo Biotherapeutics's current cash is expanding or contracting. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Latigo Biotherapeutics's current cash evolved across reporting periods, while the comparison chart places LTGO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers